Showing results (121-130 of 339) with videos related to

Sort By:
Pageof 34
Internal Medicine (Tokyo, Japan)|August 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera MyelofibrosisMakoto Murata, Ritsuro Suzuki, Tetsuya Nishida, et al.
Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 29, 2019
Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete RemissionTakaaki Konuma, Tadakazu Kondo, Shohei Mizuno, et al.
Cancer Science|October 13, 2021
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicineYutaka Shimazu, Shohei Mizuno, Shin-Ichi Fuchida, et al.
Cytotherapy|May 9, 2022
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adultsKaito Harada, Mari Morita-Fujita, Takahiro Fukuda, et al.
Bone Marrow Transplantation|January 18, 2022
Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working groupShigeo Fuji, Tsuneaki Hirakawa, Kuniko Takano, et al.
Bone Marrow Transplantation|May 8, 2023
Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?Takaaki Konuma, Hidehiro Itonaga, Ken Ishiyama, et al.
Bone Marrow Transplantation|April 4, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimensTakuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, et al.
British Journal of Haematology|June 23, 2021
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantationMomoko Nakamura, Yasuyuki Arai, Shigeki Hirabayashi, et al.
Transplantation and Cellular Therapy|August 13, 2023
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective AnalysisKazuhito Suzuki, Yutaka Shimazu, Daisuke Minakata, et al.
Pageof 34